Evotec: Craig Johnstone

Craig Johnstone will step down as chief operating officer of Evotec, effective Dec. 31. The company did not provide a reason for his departure. Johnstone joined the German firm in 2012 as senior VP of drug discovery and innovation efficiency and became chief operating officer and a member of the management board in 2019. His responsibilities will be distributed internally until a new organization structure is designed, in line with Evotec's strategic review.